4Life Research - Competitors

4Life Research Competition

Now Viewing 4Life Research's competition in: Pharmaceutical Manufacture and Sale

Recent Developments

US Exports, Imports Rise - Exports of US pharmaceuticals and medicines rose 14 percent in 2007 compared to 2006; imports rose 10.2 percent. Exports to Germany, the top destination for US-made pharmaceuticals and medicines, rose 59.1 percent. Imports rose from 10 of the 15 top suppliers of pharmaceuticals and medicines to the US.

Pharmaceutical Firms to Disclose Grants to Physicians - Top US pharmaceutical companies plan to publicly disclose grants made to groups and physicians, according to a US senator. Some experts say that the grants, which include physician consulting fees, free trips to exotic locales, and sponsorship of educational conferences that physicians attend, can improperly influence medical care. Critics say that the companies are trying to prevent the introduction of legislation that would require public disclosure of their giving.

Website Provides Drug Safety Information - A website that provides alerts on drug safety, side effects, and recalls has drawn the interest of many US consumers. Quintiles Transnational's iGuard.org site has attracted more than 125,000 users since it went online in October 2007. Quintiles thought it would take a year for the site to reach 100,000 registered users, and now expects the number of users to rise into the millions.

Competitive Landscape

The industry is marked by rapid advances in scientific knowledge that produce ever-more effective medicines. Profitability is determined mainly by the ability to discover new drugs. The industry is dominated by the large manufacturers/marketers that manufacture drugs, have large research operations, and also have large clinical testing, marketing, and distribution capabilities. Small companies are mainly research operations or manufacturers of non-prescription products. Because of the high value of the product, average revenue per employee is a very high $600,000.

Full Industry Overview For Pharmaceutical Manufacture and Sale

Pharmaceutical Manufacture and Sale Industry Forecast

from Hoover's/D&B subsidiary First Research

The output of US drug manufacturing is forecast to grow at an annual compounded rate of 11.7 percent between 2007 and 2012.

Drug Production Growth Strong

First Research forecasts are based on INFORUM forecasts that are licensed from the Interindustry Economic Research Fund, Inc. (IERF) in College Park, MD. INFORUM's "interindustry-macro" approach to modeling the economy captures the links between industries and the aggregate economy.